ClinicalTrials.gg
Not yet recruitingNCT07736508Updated Jul 30, 2026

Systemic Couple Therapy for Marital Dynamics and Mental Health

An interventional study of Systemic Couple Therapy in Depression, sponsored by Shifa Tameer-e-Millat University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Shifa Tameer-e-Millat University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial (randomized controlled trial within a mixed-method study) is to learn whether Systemic Couple Therapy (SCT) can treat depression and improve relational functioning in married couples where at least one partner is experiencing mild to moderate depression and relational distress.

The main questions it aims to answer are:

  • Does Systemic Couple Therapy improve relationship quality, marital communication, dyadic coping, interpersonal functioning, and overall mental health?
  • Does Systemic Couple Therapy reduce depressive symptoms compared to Treatment-as-Usual (TAU)? Researchers will compare Systemic Couple Therapy (intervention group) with Treatment-as-Usual (control group) to see if SCT leads to greater improvements in mental health and relational outcomes and greater reduction in depression.

Participants will:

  • Complete standardized psychological assessments at baseline, post-treatment (8 weeks), and 3-month follow-up
  • Participate in 8 weekly Systemic Couple Therapy sessions (intervention group)
  • Receive Treatment-as-Usual such as routine couple therapy services or medication (control group)
02

Conditions studied

  • Depression

Browse trials for

03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 48 is below the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Shifa Tameer-e-Millat University is the lead sponsor of 27 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion criteria

    • Participant must be 18 years or older to participate in the study.
    • At least one partner must meet the diagnostic criteria for depression (mild to moderate) as defined by the TR.
    • Participants must be married for at least a year to ensure adequate context for systemic couple therapy.
    • Both partners must agree to participate in the study, showing their willingness to engage in the intervention and complete all required assessments.

Exclusion Criteria:

    • Participants with severe depression, psychosis, bipolar disorder, or active substance use disorder will be excluded from the study due to potential interference with therapy.

      • Participants currently engaged in ongoing individual psychotherapy during the study period will be excluded to avoid confounding treatment effects.
      • Additionally, couples will be excluded if there is presence of domestic violence or abuse, as identified during the initial screening or clinical interview, to ensure participant safety.
      • Couple who will be undergoing legal separation or divorce proceedings will not be eligible to participate, as the focus of the systemic couple therapy is relational commitment and stability.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Systemic Couple Therapy

    Systemic Couple Therapy

    Behavioral: Systemic Couple Therapy

  • No intervention
    TAU

    Treatment As Usual

Interventions

  • BehavioralSystemic Couple Therapy

    Systemic Couple Therapy for Depressive Sample

06

What researchers measure

Primary outcomes

  1. Relationship Quality

    Relationship quality will be measured using the Relationship Quality Scale, a 9-item self-report questionnaire assessing participants' perceptions of the quality of their current relationship. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 9 to 45, with higher scores indicating better relationship quality. Assessments will be conducted at baseline (August) after enrollment, post-intervention (8-weeks )(September), and the 3-month follow-up (December).

    Time frame: Assessed at baseline (after enrollment and prior to intervention), immediately after completion of the 8-week intervention, and 3 months after completion of the intervention.

Secondary outcomes

  1. Depression

    Depression severity will be measured using the Patient Health Questionnaire-9, a 9-item self-report questionnaire assessing the frequency of depressive symptoms experienced during the previous two weeks. Each item is scored from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms. Assessments will be conducted at baseline (August) after enrollment, post-intervention (8-weeks )(September), and the 3-month follow-up (December).

    Time frame: Assessed at baseline (after enrollment and prior to intervention), immediately after completion of the 8-week intervention, and 3 months after completion of the intervention.

  2. Marital Communication

    Marital communication is defined as the verbal and nonverbal sharing of information among spouses. Marital communication will be assessed using the Dyadic Communication Assessment Scale. The scale consists of 16 items, each rated on a 5-point Likert scale ranging from 1 (Rarely) to 5 (Always). Total scores range from 16 to 80, with higher scores indicating better and more effective marital communication. Assessments will be conducted at baseline (August) after enrollment, post-intervention (8-weeks )(September), and the 3-month follow-up (December).

    Time frame: Assessed at baseline (after enrollment and prior to intervention), immediately after completion of the 8-week intervention, and 3 months after completion of the intervention.

  3. Dyadic coping

    Dyadic coping is the process by which couple assist each other when one or both are under stress. Dyadic coping will be assessed using the Dyadic Coping Inventory. The inventory consists of 37 items rated on a 5-point Likert scale ranging from 1 (very rarely) to 5 (very often). Total scores range from 37 to 185, with higher scores indicating more effective dyadic coping between partners. Assessments will be conducted at baseline (August) after enrollment, post-intervention (8-weeks )(September), and the 3-month follow-up (December).

    Time frame: Assessed at baseline (after enrollment and prior to intervention), immediately after completion of the 8-week intervention, and 3 months after completion of the intervention.

  4. Interpersonal relationships

    Interpersonal relationships will be assessed using the Interpersonal Relationships Rating Scale. The scale consists of 18 items rated on a 5-point Likert scale ranging from 1 (completely inconsistent) to 5 (completely consistent). Total scores range from 18 to 90, with higher scores indicating better interpersonal relationships and interpersonal functioning. Assessments will be conducted at baseline (August) after enrollment, post-intervention (8-weeks )(September), and the 3-month follow-up (December).

    Time frame: Assessed at baseline (after enrollment and prior to intervention), immediately after completion of the 8-week intervention, and 3 months after completion of the intervention.

  5. Mental Health

    Mental health will be measured using the Mental Health Inventory-38, a 38-item self-report questionnaire that assesses overall psychological well-being and psychological distress experienced during the previous month. Responses are recorded using 5-point or 6-point response options depending on the item, and scores are summed to produce a Mental Health Index ranging from 38 to 226. Higher scores indicate better overall mental health, reflecting greater psychological well-being and lower psychological distress. Assessments will be conducted at baseline (August) after enrollment, post-intervention (8-weeks )(September), and the 3-month follow-up (December).

    Time frame: Assessed at baseline (after enrollment and prior to intervention), immediately after completion of the 8-week intervention, and 3 months after completion of the intervention.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Oct 2026, 2 months later.

Of 3,468 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 2 months is below that.

Counting every sponsor, half of 3,566 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2026
First posted
Jul 30, 2026
StartEst.
Aug 1, 2026
Primary completionEst.
Oct 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07736508
Lead sponsor
Shifa Tameer-e-Millat University
Responsible party
Tamkeen Saleem (Professor of Clinical Psychology, Shifa Tameer-e-Millat University) — Principal investigator
First posted
Jul 30, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 30, 2026

Study contacts

Tamkeen Saleem, Phd
Contact
tamkeen.dcp@stmu.edu.pk
923325412281

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion